Stutterheim, J ;
de Lorenzo, P ;
van der Sluis, I. M...
Stutterheim , J , de Lorenzo , P , van der Sluis , I M , Alten , J , Ancliffe , P , Attarbaschi , A , Aversa , L , Boer , J M , Biondi , A , Brethon , B , Diaz , P , Cazzaniga , G , Escherich , G , Ferster , A , Kotecha , R S , Lausen , B , Leung , A WK , Locatelli , F , Silverman , L , Stary , J , Szczepanski , T , van der Velden , V H J , Vora , A , Zuna , J , Schrappe , M , Valsecchi , M G & Pieters , R 2022 , ' Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocol ' , European Journal of Cancer , vol. 160 , pp. 72-79 . https://doi.org/10.1016/j.ejca.2021.10.004.
,
2022
